<abstract xmlns="http://www.w3.org/1999/xhtml">
<p>This article covers various aspects of COVID-19, also known as the new coronavirus. It is caused by the SARS-CoV-2 virus and was first identified in December 2019 in Wuhan, China. The virus has rapidly spread globally and caused a pandemic. The primary mode of transmission is through respiratory droplets when an infected person talks, coughs or sneezes. While most people will experience mild or moderate symptoms, the disease can be severe and even fatal, especially for older adults and those with underlying health conditions. Additionally, the article discusses the immunopathology of SARS-CoV-2 and its effects on the immune system, as well as the neurological manifestations of COVID-19 and its impact on cerebrovascular disease.</p>
</abstract>

This article covers various aspects of COVID-19, also known as the new coronavirus. It is caused by the SARS-CoV-2 virus and was first identified in December 2019 in Wuhan, China. The virus has rapidly spread globally and caused a pandemic. The primary mode of transmission is through respiratory droplets when an infected person talks, coughs or sneezes. While most people will experience mild or moderate symptoms, the disease can be severe and even fatal, especially for older adults and those with underlying health conditions. Additionally, the article discusses the immunopathology of SARS-CoV-2 and its effects on the immune system, as well as the neurological manifestations of COVID-19 and its impact on cerebrovascular disease.

Cerebrovascular Disease and Covid-19: A Systematic Review of the Literature

ARS Medica Tomitana

This work is licensed under the Creative Commons Attribution 4.0 International License.

{"article-title":"Cerebrovascular Disease and Covid-19: A Systematic Review of the Literature"}

This article covers various aspects of COVID-19, also known as the new coronavirus. It is caused by the SARS-CoV-2 virus and was first identified in December...

Cerebrovascular Disease and Covid-19: A Systematic Review of the Literature

Pubblicato online: 05 set 2023

Pagine: 103 - 107

DOI: https://doi.org/10.2478/arsm-2022-0022

Parole chiave
COVID-19, immunopathology of SARS-CoV-2, cerebrovascular disease, neurological manifestations of COVID-19

© 2023 Lavinia Florenta Muja et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Cerebrovascular Disease and Covid-19: A Systematic Review of the Literature

Pubblicato online: 05 set 2023

Pagine: 103 - 107

DOI: https://doi.org/10.2478/arsm-2022-0022

Parole chiaveCOVID-19, immunopathology of SARS-CoV-2, cerebrovascular disease, neurological manifestations of COVID-19

© 2023 Lavinia Florenta Muja et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Parole chiave
COVID-19, immunopathology of SARS-CoV-2, cerebrovascular disease, neurological manifestations of COVID-19